Minimally invasive parathyroidectomy: 50 consecutive cases

L. Delbridge,S. Dolan,Tran Thi Hop,T. Reeve,B. Robinson,M. R. Wilkinson

DOI: https://doi.org/10.5694/j.1326-5377.2000.tb124036.x

2000-05-01

Abstract:To determine the effectiveness and outcomes of minimally invasive parathyroidectomy.

What problem does this paper attempt to address?

Association Between Socioeconomic Status and Health Behaviour Change Before and after Non-Communicable Disease Diagnoses: a Multicohort Study

Danyang Wang,Xiaochen Dai,Shiva Raj Mishra,Carmen C. W. Lim,Rodrigo M. Carrillo-Lorca,Emmanuela Gakidou,Xiaolin Xu

DOI: https://doi.org/10.1016/s2468-2667(22)00157-8

2022-01-01

Abstract:Background Behavioural risk factors of non-communicable diseases (NCDs) are socially patterned. However, the direction and the extent to which socioeconomic status (SES) influences behaviour changes before and after the diagnosis of NCDs is not clearly understood. We aimed to investigate the influence of SES on behaviour changes (physical inactivity and smoking) before and after the diagnosis of major NCDs. Methods In this multicohort study, we pooled individual-level data from six prospective cohort studies across 17 countries. We included participants who were diagnosed with either diabetes, cardiovascular disease, chronic lung disease, or cancer after recruitment. Participants were surveyed every 2 years. Education and total household wealth were used to construct SES. We measured behaviour changes as whether or not participants continued or initiated physical inactivity or smoking after NCD diagnosis. We used inultivariable logistic regression models to estimate odds ratios (ORs), prevalence ratios (PRs), and 95% CIs for the associations between SES and continuation or initiation of unfavourable behaviours. Findings We included 8107 individuals recruited between March, 2002, and January, 2016. Over the 4-year period before and after NCD diagnosis, 886 (60.4%) of 1466 individuals continued physical inactivity and 1018 (68.8%) of 1480 participants continued smoking; 1047 (15.8%) of 6641 participants with physical activity before diagnosis initiated physical inactivity after diagnosis and 132 (2.0%) of 6627 non-smokers before diagnosis initiated smoking after diagnosis. Compared with participants with high SES, those with low SES were more likely to continue physical inactivity (244 [70.3%] of 347 vs 23 [50.0%] of 46; PR 1.41 [95% CI 1.05-1.99]; OR 2.28 [1.18-4.41]), continue smoking (214 [75.4%] of 284 vs 39 [60.9%] of 64; PR 1.27 [1.03-1.59]; OR 2.08 [1.14-3.80]), but also to initiate physical inactivity (188126.1%1 of 720 vs 47 [7.4%] of 639; PR 3.59 [2.58-4.85]; OR 4.31 [3.02 - 6.14]). Interpretation Low SES was associated with continuing or initiating physical inactivity and continuing smoking after NCD diagnosis. Reducing socioeconomic inequality in health behaviour changes should be prioritised and integrated into NCD-prevention programmes. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
Mendelian Randomization to Explore the Direct or Mediating Associations Between Socioeconomic Status and Lung Cancer.

Hong Wu,Jing Yang,Hui Wang,Lei Li

DOI: https://doi.org/10.3389/fonc.2023.1143059

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:ObjectiveThe purpose of this study was to verify whether there are direct or mediated causal associations between socioeconomic status and lung cancer.MethodsPooled statistics were obtained from corresponding genome-wide association studies. The inverse-variance weighted, weighted median, MR−Egger, MR-PRESSO and contamination-mixture methods were used as supplements to Mendelian randomization (MR) statistical analysis. Cochrane’s Q value and the MR−Egger intercept were used for sensitivity analysis.ResultsIn the univariate MR analysis, household income and education had protective effects on overall lung cancer (income: P = 5.46×10-4; education: P = 4.79×10-7) and squamous cell lung cancer (income: P = 2.67×10-3; education: P = 1.42×10-10). Smoking and BMI had adverse effects on overall lung cancer (smoking: P = 2.10×10-7; BMI: P = 5.67×10-4) and squamous cell lung cancer (smoking: P = 5.02×10-6; BMI: P = 2.03×10-7). Multivariate MR analysis found that smoking and education were independent risk factors for overall lung cancer (smoking: P = 1.96×10-7; education: P = 3.11×10-3), while smoking was an independent risk factor for squamous cell lung cancer (P = 2.35×10-6). Smoking, education, and household income mediate the effect of BMI on overall lung cancer (smoking 50.0%, education 49.2%, income 25.3%) and squamous cell lung cancer (smoking 34.8%, education 30.8%, income 21.2%). Smoking, education, and BMI mediate the effect of income on overall lung cancer (smoking 13.9%, education 54.8%, BMI 9.4%) and squamous cell lung cancer (smoking 12.6%, education 63.3%, BMI 11.6%). Smoking, BMI, and income mediate the effect of education on squamous cell lung cancer (smoking 24.0%, BMI 6.2%, income 19.4%).ConclusionIncome, education, BMI, and smoking are causally associated with both overall lung cancer and squamous cell lung cancer. Smoking and education are independent association factors for overall lung cancer, while smoking is an independent association factor for squamous cell lung cancer. Smoking and education also play important mediating roles in overall lung cancer and squamous cell lung cancer. No causal relationship was found between multiple risk factors associated with socioeconomic status and lung adenocarcinoma.
Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Yongtang Jin,Heyun Xu,Chunye zhang,Yunming Kong,Yong Hou,Yingchun Xu,Shaoli Xue

DOI: https://doi.org/10.1186/1471-2407-10-422

IF: 4.638

2010-01-01

BMC Cancer

Abstract:BACKGROUND:Cigarette smoking is the most established risk factor, and genetic variants and/or gene promoter methylations are also considered to play an essential role in development of lung cancer, but the pathogenesis of lung cancer is still unclear.METHODS:We collected the data of 150 cases and 150 age-matched and sex-matched controls on a Hospital-Based Case-Control Study in China. Face to face interviews were conducted using a standardized questionnaire. Gene polymorphism and methylation status were measured by RFLP-PCR and MSP, respectively. Logistic regressive model was used to estimate the odds ratios (OR) for different levels of exposure.RESULTS:After adjusted age and other potential confounding factors, smoking was still main risk factor and significantly increased 3.70-fold greater risk of NSCLC as compared with nonsmokers, and the ORs across increasing levels of pack years were 1, 3.54, 3.65 and 7.76, which the general dose-response trend was confirmed. Our striking findings were that the risk increased 5.16, 8.28 and 4.10-fold, respectively, for NSCLC with promoter hypermethylation of the p16, DAPK or RAR beta gene in smokers with CYP1A1 variants, and the higher risk significantly increased in smokers with null GSTM1 and the OR was 17.84 for NSCLC with p16 promoter hypermethylation, 17.41 for DAPK, and 8.18 for RAR beta in smokers with null GSTM1 compared with controls (all p < 0.01).CONCLUSION:Our study suggests the strong combined effects of cigarette smoke, CYP1A1 and GSTM1 Polymorphisms, hypermethylations of p16, DAPK and RAR beta promoters in NSCLC, implying complex pathogenesis of NSCLC should be given top priority in future research.
[Temporal arteritis. Study of 43 cases].

J. Villalta,J. Vilaseca,M. Ingelmo,L. González,J. Tor,A. Coca,R. Bacardi,A. Balcells-Gorina

1982-04-16

Abstract:
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study

Robert Carreras-Torres,Mattias Johansson,Philip C. Haycock,Kaitlin H. Wade,Caroline L. Relton,Richard M. Martin,George Davey Smith,Demetrius Albanes,Melinda C. Aldrich,Angeline Andrew,Susanne M. Arnold,Heike Bickeböller,Stig E. Bojesen,Hans Brunnström,Jonas Manjer,Irene Brüske,Neil E. Caporaso,Chu Chen,David C. Christiani,W. Jay Christian,Jennifer A. Doherty,Eric J. Duell,John K. Field,Michael P. A. Davies,Michael W. Marcus,Gary E. Goodman,Kjell Grankvist,Aage Haugen,Yun-Chul Hong,Lambertus A. Kiemeney,Erik H. F. M. van der Heijden,Peter Kraft,Mikael B. Johansson,Stephen Lam,Maria Teresa Landi,Philip Lazarus,Loïc Le Marchand,Geoffrey Liu,Olle Melander,Sungshim L. Park,Gad Rennert,Angela Risch,Eric B. Haura,Ghislaine Scelo,David Zaridze,Anush Mukeriya,Milan Savić,Jolanta Lissowska,Beata Swiatkowska,Vladimir Janout,Ivana Holcatova,Dana Mates,Matthew B. Schabath,Hongbing Shen,Adonina Tardon,M Dawn Teare,Penella Woll,Ming-Sound Tsao,Xifeng Wu,Jian-Min Yuan,Rayjean J. Hung,Christopher I. Amos,James McKay,Paul Brennan

DOI: https://doi.org/10.1371/journal.pone.0177875

IF: 3.7

2017-06-08

PLoS ONE

Abstract:BACKGROUND: Assessing the relationship between lung cancer and metabolic conditions is challenging because of the confounding effect of tobacco. Mendelian randomization (MR), or the use of genetic instrumental variables to assess causality, may help to identify the metabolic drivers of lung cancer.METHODS AND FINDINGS: We identified genetic instruments for potential metabolic risk factors and evaluated these in relation to risk using 29,266 lung cancer cases (including 11,273 adenocarcinomas, 7,426 squamous cell and 2,664 small cell cases) and 56,450 controls. The MR risk analysis suggested a causal effect of body mass index (BMI) on lung cancer risk for two of the three major histological subtypes, with evidence of a risk increase for squamous cell carcinoma (odds ratio (OR) [95% confidence interval (CI)] = 1.20 [1.01-1.43] and for small cell lung cancer (OR [95%CI] = 1.52 [1.15-2.00]) for each standard deviation (SD) increase in BMI [4.6 kg/m2]), but not for adenocarcinoma (OR [95%CI] = 0.93 [0.79-1.08]) (Pheterogeneity = 4.3x10-3). Additional analysis using a genetic instrument for BMI showed that each SD increase in BMI increased cigarette consumption by 1.27 cigarettes per day (P = 2.1x10-3), providing novel evidence that a genetic susceptibility to obesity influences smoking patterns. There was also evidence that low-density lipoprotein cholesterol was inversely associated with lung cancer overall risk (OR [95%CI] = 0.90 [0.84-0.97] per SD of 38 mg/dl), while fasting insulin was positively associated (OR [95%CI] = 1.63 [1.25-2.13] per SD of 44.4 pmol/l). Sensitivity analyses including a weighted-median approach and MR-Egger test did not detect other pleiotropic effects biasing the main results.CONCLUSIONS: Our results are consistent with a causal role of fasting insulin and low-density lipoprotein cholesterol in lung cancer etiology, as well as for BMI in squamous cell and small cell carcinoma. The latter relation may be mediated by a previously unrecognized effect of obesity on smoking behavior.

multidisciplinary sciences
Abstract 1950: Socioeconomic status and lung cancer incidence: An analysis of data from 15 countries in the Lung Cancer Cohort Consortium

Justina U. Onwuka,Hana Zahed,Xiaoshuang Feng,Karine Alcala,Mattias Johansson,Hilary A. Robbins,Lung Cancer Cohort Consortium

DOI: https://doi.org/10.1158/1538-7445.am2023-1950

IF: 11.2

2023-04-04

Cancer Research

Abstract:Abstract Background: Lung cancer is the leading cause of cancer death worldwide. We explored the relationship between socioeconomic status and lung cancer incidence across world regions, using educational level as a proxy for socioeconomic status. Methods: We analyzed the harmonized database of the Lung Cancer Cohort Consortium (LC3). The current study included data from 18 prospective cohorts from 15 countries in the US, Europe, Asia, and Australia. Separately for participants who never or currently/formerly smoked, we estimated the association between educational level and incident lung cancer using Cox proportional hazards models. Information on education was harmonized using the International Standard Classification of Education and then modeled as an ordinal variable in 4 categories. Models were adjusted for age, sex, and for participants who currently/formerly smoked, smoking duration, cigarettes per day, and time since cessation. Results: Among 2.6 million participants from 15 countries, 62,645 developed lung cancer during follow-up (median follow-up = 12.6 years). Among current/former smokers, increased educational level was associated with decreased lung cancer incidence in most cohorts after adjustment for age, sex, and detailed smoking information, with HRs ranging from 0.77 (95%CI: 0.42-1.41) per 1-unit increase in educational level in the Iranian Golestan Cohort Study to 1.02 (95%CI: 0.95-1.09) in the Australian Melbourne Collaborative Cohort Study. When grouping by world region, the association between education and lung cancer incidence among currently/formerly smoking participants was similar for the US (HRpooled=0.88, 95%CI: 0.87-0.89), Europe (HRpooled=0.89, 95%CI: 0.88-0.91), and Asia (HRpooled=0.91, 95%CI: 0.86-0.96), but attenuated in the Australian cohort (HR=1.02, 95%CI: 0.95-1.09). Among never smokers, after adjustment for age and sex, there was no statistically significant association between educational level and lung cancer incidence (p-trend>0.05 in all cohorts), with the exception of the US Southern Community Cohort Study, which comprises primarily African-Americans and showed a HR of 0.75 (95%CI: 0.62-0.90). Conclusion: Among currently and formerly smoking individuals, higher educational level showed a strikingly consistent decreased risk of incident lung cancer across cohorts from 4 continents, after detailed adjustment for smoking. In contrast, among people who never smoked, there was no association between education and lung cancer incidence in any cohort, with the exception of the Southern Community Cohort Study. Further research is needed to clarify the mechanisms, either related or unrelated to smoking, that contribute to the association between education and lung cancer risk. Citation Format: Justina U. Onwuka, Hana Zahed, Xiaoshuang Feng, Karine Alcala, Mattias Johansson, Hilary A. Robbins, Lung Cancer Cohort Consortium. Socioeconomic status and lung cancer incidence: An analysis of data from 15 countries in the Lung Cancer Cohort Consortium [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1950.

oncology
Abstract C173: Influence of Socio-Demographic and Lifestyle Factors on Lung Cancer Incidence Among African American and European American

Murugesh Eswaran,Briana A Briana A Brock,Hina Abdulrehman Mir,Eric L. Flenaugh,Oprea M. Gabriela,Brian Rivers,Rajesh Singh,Shailesh Singh

DOI: https://doi.org/10.1158/1538-7755.disp24-c173

2024-09-23

Cancer Epidemiology Biomarkers & Prevention

Abstract:The persistent gap in cancer incidence and outcomes between African American (AA) and European American (EA) populations remains a significant public health challenge. Understanding these discrepancies is pivotal for crafting targeted interventions to mitigate health disparities. To comprehensively assess these inequalities, this study delves into the association between smoking and lung cancer incidence within a diverse cohort of 5270 participants, comprising both AA (868 participants) and EA (3137 participants) individuals. Among the 2901 lung cancer patients identified in our analysis, diagnoses ranged from Malignant Tumors of the Lung to various subtypes of Non-Small Cell and Small Cell Lung Cancer. Surprisingly, only a significant subset of these patients were smokers, with statistical analysis indicating a p<0.001, pointing to other influential demographic factors. Employing the Chi-Square Test of Independence, Logistic Regression, and Multivariate Analysis, we evaluated the impact of smoking alongside additional variables on lung cancer incidence. Factors such as Age, Gender, Socioeconomic Status, Occupational Exposures, Geographic Location, Family History of Cancer, Comorbidities, and Lifestyle Factors were considered in the multivariate analyses to ascertain their contribution to lung cancer risks. Our findings from Relative Risk (RR) and Attributable Risk (AR) assessments suggest that while smoking constitutes a notable risk factor, a substantial proportion of lung cancer cases in this cohort were not linked to smoking. Stratified and Sensitivity Analyses further unveiled nuanced risk profiles within subgroups, elucidating the intricate interplay between lifestyle factors and genetic predispositions. Our study highlights that a significant portion of lung cancer cases, particularly among EA and AA populations, occur in non-smokers, with smoking often associated with other comorbidities rather than solely lung- specific diseases. This underscores the multifaceted nature of lung cancer risk factors across different racial groups, advocating for public health strategies that address a broader spectrum of influences beyond smoking to combat cancer disparities within these communities effectively. Citation Format: Murugesh Eswaran, Briana A Briana A Brock, Hina Abdulrehman Mir, Eric L. Flenaugh, Oprea M. Gabriela, Brian Rivers, Rajesh Singh, Shailesh Singh. Influence of Socio-Demographic and Lifestyle Factors on Lung Cancer Incidence Among African American and European American [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr C173.

oncology,public, environmental & occupational health
Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY)

Ann Olsson,Liacine Bouaoun,Joachim Schüz,Roel Vermeulen,Thomas Behrens,Calvin Ge,Hans Kromhout,Jack Siemiatycki,Per Gustavsson,Paolo Boffetta,Benjamin Kendzia,Loredana Radoi,Christine Barul,Stefan Karrasch,Heinz-Erich Wichmann,Dario Consonni,Maria Teresa Landi,Neil E. Caporaso,Franco Merletti,Enrica Migliore,Lorenzo Richiardi,Karl-Heinz Jöckel,Wolfgang Ahrens,Hermann Pohlabeln,Guillermo Fernández-Tardón,David Zaridze,John K. Field,Jolanta Lissowska,Beata Świątkowska,John R. McLaughlin,Paul A. Demers,Miriam Schejbalova,Lenka Foretova,Vladimir Janout,Tamás Pándics,Eleonora Fabianova,Dana Mates,Francesco Forastiere,Kurt Straif,Thomas Brüning,Jelle Vlaanderen,Susan Peters

DOI: https://doi.org/10.1289/ehp13380

IF: 11.035

2024-01-19

Environmental Health Perspectives

Abstract:BACKGROUND: While much research has been done to identify individual workplace lung carcinogens, little is known about joint effects on risk when workers are exposed to multiple agents.

environmental sciences,public, environmental & occupational health,toxicology
Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

Yajing Zhou,Xuan Zhou,Jing Sun,Lijuan Wang,Jianhui Zhao,Jie Chen,Shuai Yuan,Yazhou He,Maria Timofeeva,Athina Spiliopoulou,Ines Mesa-Eguiagaray,Susan M. Farrington,Kefeng Ding,Malcolm G. Dunlop,Xiao Qian,Evropi Theodoratou,Xue Li

DOI: https://doi.org/10.1002/ijc.34656

2023-01-01

International Journal of Cancer

Abstract:Aberrant smoking-related DNA methylation has been widely investigated as a carcinogenesis mechanism, but whether the cross-cancer epigenetic pathways exist remains unclear. We conducted two-sample Mendelian randomization (MR) analyses respectively on smoking behaviors (age of smoking initiation, smoking initiation, smoking cessation, and lifetime smoking index [LSI]) and smoking-related DNA methylation to investigate their effect on 15 site-specific cancers, based on a genome-wide association study (GWAS) of 1.2 million European individuals and an epigenome-WAS (EWAS) of 5907 blood samples of Europeans for smoking and 15 GWASs of European ancestry for multiple site-specific cancers. Significantly identified CpG sites were further used for colocalization analysis, and those with cross-cancer effect were validated by overlapping with tissue-specific eQTLs. In the genomic MR, smoking measurements of smoking initiation, smoking cessation and LSI were suggested to be casually associated with risk of seven types of site-specific cancers, among which cancers at lung, cervix and colorectum were provided with strong evidence. In the epigenetic MR, methylation at 75 CpG sites were reported to be significantly associated with increased risks of multiple cancers. Eight out of 75 CpG sites were observed with cross-cancer effect, among which cg06639488 (EFNA1), cg12101586 (CYP1A1) and cg14142171 (HLA-L) were validated by eQTLs at specific cancer sites, and cg07932199 (ATXN2) had strong evidence to be associated with cancers of lung (coefficient, 0.65, 95% confidence interval [CI], 0.31-1.00), colorectum (0.90 [0.61, 1.18]), breast (0.31 [0.20, 0.43]) and endometrium (0.98 [0.68, 1.27]). These findings highlight the potential practices targeting DNA methylation-involved cross-cancer pathways.
Effect of Socioeconomic Status on Stage at Diagnosis of Lung Cancer in a Hospital-Based Multicenter Retrospective Clinical Epidemiological Study in China, 2005-2014.

Yuanqiu Li,Jufang Shi,Shicheng Yu,Le Wang,Jianjun Liu,Jiansong Ren,Shugeng Gao,Zhouguang Hui,Junling Li,Ning Wu,Boyan Yang,Shangmei Liu,Mingfang Qin,Debin Wang,Xianzhen Liao,Xiaojing Xing,Lingbin Du,Li Yang,Yuqin Liu,Yongzhen Zhang,Kai Zhang,Youlin Qiao,Jie He,Min Dai,Hongyan Yao,Health Economic Evaluation Working Group, Cancer Screening Program in Urban China (CanSPUC)

DOI: https://doi.org/10.1002/cam4.1170

IF: 4.711

2017-01-01

Cancer Medicine

Abstract:There is inconsistent evidence of associations between socioeconomic status (SES) and lung cancer stage in non-Chinese populations up to now. We set out to determine how SES affects stage at diagnosis at both individual and area levels, from a hospital-based multicenter 10-year (2005-2014) retrospective clinical epidemiological study of 7184 primary lung cancer patients in mainland China. Individual-level SES data were measured based on two indicators from case report forms of the study: an individual's education and occupation. Seven census indicator variables were used as surrogates for the area-level SES with principal component analysis (PCA). Multivariate analysis was undertaken using binary logistic regressions and multinomial logit model to describe the association and explore the effect across tertiles on stage after adjusting for demographic variables. There was a significant stepwise gradient of effect across different stages in the highest tertile of area-level SES, comparing with the lowest tertile of area-level SES (ORs, 0.77, 0.67, and 0.29 for stage II, III, and IV). Patients with higher education were less likely to have stage IV lung cancer, comparing with the illiterate group (ORs, 0.52, 0.63, 0.71, 0.64 for primary school, middle school, high school, college degree or above subgroup, respectively). Findings suggest that the most socioeconomically deprived areas may be associated with a higher risk of advanced-stage lung cancer, and increasing educational level may be correlated with a lower risk to be diagnosed at advanced stage in both men and women.
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

Limin X. Clegg,Marsha E. Reichman,Barry A. Miller,Benjamin F. Hankey,Gopal K. Singh,Yi Dan Lin,Marc T. Goodman,Charles F. Lynch,Stephen M. Schwartz,Vivien W. Chen,Leslie Bernstein,Scarlett L. Gomez,John J. Graff,Charles C. Lin,Norman J. Johnson,Brenda K. Edwards

DOI: https://doi.org/10.1007/s10552-008-9256-0

2008-11-12

Abstract:BackgroundPopulation-based cancer registry data from the Surveillance, Epidemiology, and End Results (SEER) Program at the National Cancer Institute (NCI) are mainly based on medical records and administrative information. Individual-level socioeconomic data are not routinely reported by cancer registries in the United States because they are not available in patient hospital records. The U.S. representative National Longitudinal Mortality Study (NLMS) data provide self-reported, detailed demographic and socioeconomic data from the Social and Economic Supplement to the Census Bureau’s Current Population Survey (CPS). In 1999, the NCI initiated the SEER-NLMS study, linking the population-based SEER cancer registry data to NLMS data. The SEER-NLMS data provide a new unique research resource that is valuable for health disparity research on cancer burden. We describe the design, methods, and limitations of this data set. We also present findings on cancer-related health disparities according to individual-level socioeconomic status (SES) and demographic characteristics for all cancers combined and for cancers of the lung, breast, prostate, cervix, and melanoma.MethodsRecords of cancer patients diagnosed in 1973–2001 when residing 1 of 11 SEER registries were linked with 26 NLMS cohorts. The total number of SEER matched cancer patients that were also members of an NLMS cohort was 26,844. Of these 26,844 matched patients, 11,464 were included in the incidence analyses and 15,357 in the late-stage diagnosis analyses. Matched patients (used in the incidence analyses) and unmatched patients were compared by age group, sex, race, ethnicity, residence area, year of diagnosis, and cancer anatomic site. Cohort-based age-adjusted cancer incidence rates were computed. The impact of socioeconomic status on cancer incidence and stage of diagnosis was evaluated.ResultsMen and women with less than a high school education had elevated lung cancer rate ratios of 3.01 and 2.02, respectively, relative to their college educated counterparts. Those with family annual incomes less than $12,500 had incidence rates that were more than 1.7 times the lung cancer incidence rate of those with incomes $50,000 or higher. Lower income was also associated with a statistically significantly increased risk of distant-stage breast cancer among women and distant-stage prostate cancer among men.ConclusionsSocioeconomic patterns in incidence varied for specific cancers, while such patterns for stage were generally consistent across cancers, with late-stage diagnoses being associated with lower SES. These findings illustrate the potential for analyzing disparities in cancer outcomes according to a variety of individual-level socioeconomic, demographic, and health care characteristics, as well as by area measures available in the linked database.

oncology,public, environmental & occupational health
Impurity band and magnetic-field-induced metal-insulator transition in a doped GaAs/AlxGa1-xAs superlattice.

W. Hilber,M. Helm,F. M. Peeters,Kambiz Alavi,R. N. Pathak

DOI: https://doi.org/10.1103/PHYSREVB.53.6919

1996-03-15

Abstract:A combination of infrared spectroscopy and magnetotransport is used to investigate the impurity band and the magnetic-ﬁeld-induced metal-insulator transition in n -type GaAs/Al x Ga 1 (cid:50) x As superlattices. The dropping of the Fermi level from the conduction band into the impurity band upon increasing magnetic ﬁeld is observed in a sample doped to n (cid:53) 4 n c , where n c is the critical density according to the Mott criterion. The metal-insulator transition takes place while the Fermi level is in the impurity band, with no qualitative change from the metallic to the insulating side. Due to the anisotropy of the superlattice band structure, the metal-insulator transition is shifted to higher magnetic ﬁeld, when the magnetic ﬁeld is tilted away from the growth axis towards the layer planes
From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Chen Zhishan,Wen Wanqing,Cai Qiuyin,Long Jirong,Wang Ying,Lin Weiqiang,Shu Xiao-ou,Zheng Wei,Guo Xingyi

DOI: https://doi.org/10.1186/s12885-020-07368-1

IF: 4.638

2020-01-01

BMC Cancer

Abstract:Background Tobacco smoking is associated with a unique mutational signature in the human cancer genome. It is unclear whether tobacco smoking-altered DNA methylations and gene expressions affect smoking-related mutational signature. Methods We systematically analyzed the smoking-related DNA methylation sites reported from five previous casecontrol studies in peripheral blood cells to identify possible target genes. Using the mediation analysis approach, we evaluated whether the association of tobacco smoking with mutational signature is mediated through altered DNA methylation and expression of these target genes in lung adenocarcinoma tumor tissues. Results Based on data obtained from 21,108 blood samples, we identified 374 smoking-related DNA methylation sites, annotated to 248 target genes. Using data from DNA methylations, gene expressions and smoking-related mutational signature generated from ~ 7700 tumor tissue samples across 26 cancer types from The Cancer Genome Atlas (TCGA), we found 11 of the 248 target genes whose expressions were associated with smoking-related mutational signature at a Bonferroni-correction P < 0.001. This included four for head and neck cancer, and seven for lung adenocarcinoma. In lung adenocarcinoma, our results showed that smoking increased the expression of three genes, AHRR , GPR15 , and HDGF , and decreased the expression of two genes, CAPN8 , and RPS6KA1 , which were consequently associated with increased smoking-related mutational signature. Additional evidence showed that the elevated expression of AHRR and GPR15 were associated with smoking-altered hypomethylations at cg14817490 and cg19859270, respectively, in lung adenocarcinoma tumor tissues. Lastly, we showed that decreased expression of RPS6KA1 , were associated with poor survival of lung cancer patients. Conclusions Our findings provide novel insight into the contributions of tobacco smoking to carcinogenesis through the underlying mechanisms of the elevated mutational signature by altered DNA methylations and gene expressions.
Family Socioeconomic Position and Lung Cancer Risk: A Meta-Analysis and a Mendelian Randomization Study

Xusen Zou,Runchen Wang,Zhao Yang,Qixia Wang,Wenhai Fu,Zhenyu Huo,Fan Ge,Ran Zhong,Yu Jiang,Jiangfu Li,Shan Xiong,Wen Hong,Wenhua Liang

DOI: https://doi.org/10.3389/fpubh.2022.780538

IF: 5.2

2022-06-07

Frontiers in Public Health

Abstract:Background: Family socioeconomic position (SEP) in childhood is an important factor to predict some chronic diseases. However, the association between family SEP in childhood and the risk of lung cancer is not clear. Methods: A systematic search was performed to explore their relationship. We selected education level, socioeconomic positions of parents and childhood housing conditions to represent an individual family SEP. Hazard ratios (HRs) of lung cancer specific-mortality were synthesized using a random effects model. Two-sample Mendelian randomization (MR) was carried out with summary data from published genome-wide association studies of SEP to assess the possible causal relationship of SEP and risk of lung cancer. Results: Through meta-analysis of 13 studies, we observed that to compared with the better SEP, the poorer SEP in the childhood was associated with the increased lung cancer risk in the adulthood (HR: 1.25, 95% CI: 1.10 to 1.43). In addition, the dose-response analysis revealed a positive correlation between the poorer SEP and increased lung cancer risk. Same conclusion was reached in MR [(education level) OR 0.50, 95% CI: 0.39 to 0.63; P < 0.001]. Conclusion: This study indicates that poor family socioeconomic position in childhood is causally correlated with lung cancer risk in adulthood. Systematic Review Registration: identifier: 159082.

public, environmental & occupational health
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

Wen Zhou,Geoffrey Liu,Rayjean J. Hung,Philip C. Haycock,Melinda C. Aldrich,Angeline S. Andrew,Susanne M. Arnold,Heike Bickeböller,Stig E. Bojesen,Paul Brennan,Hans Brunnström,Olle Melander,Neil E. Caporaso,Maria Teresa Landi,Chu Chen,Gary E. Goodman,David C. Christiani,Angela Cox,John K. Field,Mikael Johansson,Lambertus A. Kiemeney,Stephen Lam,Philip Lazarus,Loïc Le Marchand,Gad Rennert,Angela Risch,Matthew B. Schabath,Sanjay S. Shete,Adonina Tardón,Shanbeh Zienolddiny,Hongbing Shen,Christopher I. Amos

DOI: https://doi.org/10.1002/ijc.33292

2020-09-23

International Journal of Cancer

Abstract:At the time of cancer diagnosis, body mass index (BMI) is inversely correlated with lung cancer risk, which may reflect reverse causality and confounding due to smoking behavior. We used two‐sample univariable and multivariable Mendelian randomization (MR) to estimate causal relationships of BMI and smoking behaviors on lung cancer and histological subtypes, based on an aggregated genome wide association studies (GWASs) analysis of lung cancer in 29 266 cases and 56 450 controls. We observed a positive causal effect for high BMI on occurrence of small cell lung cancer (odds ratio (OR) = 1.60, 95% confidence interval (CI) = 1.24‐2.06, P = 2.70 x 10−4). After adjustment of smoking behaviors using multivariable Mendelian randomization (MVMR), a direct causal effect on small cell lung cancer (ORMVMR = 1.28, 95% CI = 1.06‐1.55, PMVMR = 0.011), and an inverse effect on lung adenocarcinoma (ORMVMR = 0.86, 95% CI = 0.77‐0.96, PMVMR = 0.008) were observed. A weak increased risk of lung squamous cell carcinoma was observed for higher BMI in univariable Mendelian randomization (UVMR) analysis (ORUVMR = 1.19, 95% CI = 1.01‐1.40, PUVMR = 0.036), but this effect disappeared after adjustment of smoking (ORMVMR = 1.02, 95% CI = 0.90‐1.16, PMVMR = 0.746). These results highlight the histology‐specific impact of BMI on lung carcinogenesis and imply mediator role of smoking behaviors in the association between BMI and lung cancer.This article is protected by copyright. All rights reserved.

oncology
Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies

Calvin Ge,Susan Peters,Ann Olsson,Lützen Portengen,Joachim Schüz,Josué Almansa,Thomas Behrens,Beate Pesch,Benjamin Kendzia,Wolfgang Ahrens,Vladimir Bencko,Simone Benhamou,Paolo Boffetta,Bas Bueno-de-Mesquita,Neil Caporaso,Dario Consonni,Paul Demers,Eleonóra Fabiánová,Guillermo Fernández-Tardón,John Field,Francesco Forastiere,Lenka Foretova,Pascal Guénel,Per Gustavsson,Vikki Ho,Vladimir Janout,Karl-Heinz Jöckel,Stefan Karrasch,Maria Teresa Landi,Jolanta Lissowska,Danièle Luce,Dana Mates,John McLaughlin,Franco Merletti,Dario Mirabelli,Nils Plato,Hermann Pohlabeln,Lorenzo Richiardi,Peter Rudnai,Jack Siemiatycki,Beata Świątkowska,Adonina Tardón,Heinz-Erich Wichmann,David Zaridze,Thomas Brüning,Kurt Straif,Hans Kromhout,Roel Vermeulen

DOI: https://doi.org/10.1164/rccm.201910-1926OC

2020-08-01

Abstract:Rationale: Millions of workers around the world are exposed to respirable crystalline silica. Although silica is a confirmed human lung carcinogen, little is known regarding the cancer risks associated with low levels of exposure and risks by cancer subtype. However, little is known regarding the disease risks associated with low levels of exposure and risks by cancer subtype.Objectives: We aimed to address current knowledge gaps in lung cancer risks associated with low levels of occupational silica exposure and the joint effects of smoking and silica exposure on lung cancer risks.Methods: Subjects from 14 case-control studies from Europe and Canada with detailed smoking and occupational histories were pooled. A quantitative job-exposure matrix was used to estimate silica exposure by occupation, time period, and geographical region. Logistic regression models were used to estimate exposure-disease associations and the joint effects of silica exposure and smoking on risk of lung cancer. Stratified analyses by smoking history and cancer subtypes were also performed.Measurements and Main Results: Our study included 16,901 cases and 20,965 control subjects. Lung cancer odds ratios ranged from 1.15 (95% confidence interval, 1.04-1.27) to 1.45 (95% confidence interval, 1.31-1.60) for groups with the lowest and highest cumulative exposure, respectively. Increasing cumulative silica exposure was associated (P trend < 0.01) with increasing lung cancer risks in nonsilicotics and in current, former, and never-smokers. Increasing exposure was also associated (P trend ≤ 0.01) with increasing risks of lung adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. Supermultiplicative interaction of silica exposure and smoking was observed on overall lung cancer risks; superadditive effects were observed in risks of lung cancer and all three included subtypes.Conclusions: Silica exposure is associated with lung cancer at low exposure levels. An exposure-response relationship was robust and present regardless of smoking, silicosis status, and cancer subtype.
The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis

Zhenghua Cao,Shengkun Zhao,Tong Wu,Huan Ding,Zhiyu Tian,Feng Sun,Zhuo Feng,Shaodan Hu,Li Shi

DOI: https://doi.org/10.3389/fonc.2024.1438851

IF: 4.7

2024-11-05

Frontiers in Oncology

Abstract:Objective: Lung cancer, the most prevalent malignancy, is typically diagnosed at an advanced stage. Smoking is a pivotal risk factor for NSCLC, yet the impact of various smoking statuses on NSCLC remains unclear. Thus, this study aims to explore whether different smoking statuses can causally influence NSCLC through effects on predictive targets, offering a novel perspective for NSCLC treatment. Methods: Employing dual-sample MR, MVMR, and TSMR approaches, we assessed the causal relationships between 13 distinct smoking statuses and NSCLC, using predicted potential therapeutic targets as mediators to further elucidate the causal interplay among them. Results: Among the 13 smoking statuses, current tobacco smoking, exposure to tobacco smoke outside the home, past tobacco smoking, and never smoked demonstrated causal relationships with NSCLC. MVMR analysis reveals that Current tobacco smoking is an independent risk factor for NSCLC. Utilizing NCAPD2, IL11RA, and MLC1 as mediators, IL11RA (22.2%) was found to potentially mediate the relationship between past tobacco smoking and NSCLC. Conclusion: This study, integrating bioinformatics and MR analysis, identified three potential predictive targets as mediators to investigate the causal relationships between different smoking statuses and NSCLC through potential therapeutic targets, providing new insights for the treatment and prevention of NSCLC.

oncology
Abstract 2292: Lung Function and Lung Cancer Risk: a Mendelian Randomization Study of UK Biobank Cohort and the International Lung Cancer Consortium

Linda Kachuri,Mattias Johansson,Paul Brennan,Phillip Haycock,Geoffrey Liu,Maria Teresa Landi,David C. Christiani,Neil E. Caporaso,Xifeng Wu,Melinda C. Aldrich,Demetrius Albanes,Adonina Tardon,Gad Rennert,Chu Chen,Gary E. Goodman,Jennifer A. Doherty,Heike Bickeboller,Dawn Teare,Lambertus A. Kiemeney,Stig E. Bojesen,John K. Field,Aage Haugen,Stephen Lam,Loic Le Marchand,Matthew B. Schabath,Angeline S. Andrew,Jonas Manjer,Philip Lazarus,Susanne M. Arnold,Valerie Gaborieau,Richard Martin,Caroline Relton,George Davey Smith,Christopher I. Amos,James D. Mckay,Rayjean J. Hung

DOI: https://doi.org/10.1158/1538-7445.am2017-2292

IF: 11.2

2017-01-01

Cancer Research

Abstract:Abstract Background: Impaired lung function (LF) is strongly associated with increased lung cancer risk. However, since airflow obstruction is a diagnostic criterion for obstructive lung disease, and a consequence of tobacco smoking, isolating the causal relationship between LF and lung cancer has remained a challenge. Methods: We investigated 3 standardized (mean=0, standard deviation=1) LF metrics: forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC. To evaluate the causal relevance of LF in lung cancer etiology we conducted: i) survival analyses in the UK Biobank cohort (UKB); and ii) Mendelian Randomization (MR) analyses using genetic instrumental variables (IVs) developed in UKB and tested using individual-level data from the OncoArray, a genome-wide array with in-depth coverage for common cancers. Results: 702 incident lung cancers were diagnosed in 484,194 UKB participants during follow-up. Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI), adjusted for age, sex, smoking status, socioeconomic status, and assessment center. Adjustment for other smoking metrics yielded similar results. Lung cancer risk increased per 1 unit decrease in FEV1 (HR=1.80, 95% CI: 1.64-1.98, p=3.3×10-34), FVC (HR=1.45, 1.30-1.60, p=2.3×10-12), and FEV1/FVC (HR=1.39, 1.33-1.46, p=1.3×10-38). This pattern was observed for adenocarcinoma (n=300): FEV1 (HR=1.77, p=6.0×10-12), FVC (HR=1.48, p=1.4×10-5), FEV1/FVC (HR=1.34, p=8.3×10-11); and squamous cell carcinoma (n=166): FEV1 (HR=1.97, p=9.9×10-10), FVC (HR=1.60, p=1.0×10-4), FEV1/FVC (HR=1.38, p=5.9×10-8). Next, a genome-wide association study of 67,708 UKB participants and 12.6 million variants was carried out to develop genetic IVs for LF. Results were filtered to retain independent variants (R2<0.2) associated with each LF phenotype (p<5×10-8). The following IVs were developed: FEV1 (n=28 variants, 0.72% of variation explained), FVC (n=44, 1.08%), and FEV1/FVC (n=45, 1.85%). Odds ratios (OR) for each IV and lung cancer were estimated for 18,686 cases 15,190 controls (>80% European ancestry) from 23 studies. Effect estimates were combined using maximum-likelihood MR models to estimate causal ORs. MR results indicate that genetic scores associated with improved airflow are unrelated to lung cancer risk: FEV1 (OR=1.00, 95% CI: 0.96-1.03, p=0.86), FVC (OR=1.00, 0.97-1.03, p=0.93) and FEV1/FVC (OR=1.00, 0.91-1.10, p=0.95). The null association observed for the genetic determinants of FEV1, FVC and FEV1/FVC was not modified by tumor histology or smoking status. Conclusions: LF is a robust predictor of lung cancer risk, however, our findings do not support the existence of causal pathways that are independent of obstructive lung disease or smoking. This apparent lack of a causal relationship should be interpreted with caution since pleiotropic effects of LF loci cannot be ruled out. Citation Format: Linda Kachuri, Mattias Johansson, Paul Brennan, Phillip Haycock, Geoffrey Liu, Maria Teresa Landi, David C. Christiani, Neil E. Caporaso, Xifeng Wu, Melinda C. Aldrich, Demetrius Albanes, Adonina Tardón, Gad Rennert, Chu Chen, Gary E. Goodman, Jennifer A. Doherty, Heike Bickeböller, Dawn Teare, Lambertus A. Kiemeney, Stig E. Bojesen, John K. Field, Aage Haugen, Stephen Lam, Loic Le Marchand, Matthew B. Schabath, Angeline S. Andrew, Jonas Manjer, Philip Lazarus, Susanne M. Arnold, Valérie Gaborieau, Richard Martin, Caroline Relton, George Davey Smith, Christopher I. Amos, James D. McKay, Rayjean J. Hung. Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2292. doi:10.1158/1538-7445.AM2017-2292
Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial

Michael P A Davies,Daniel Vulkan,Rhian Gabe,Stephen W Duffy,John K Field

DOI: https://doi.org/10.1016/j.lanepe.2024.100936

2024-05-20

Abstract:Background: Lower socioeconomic status, as measured by the Index of Multiple Deprivation (IMD), is associated with higher rates of smoking-related disease mortality, and with poor uptake of cancer screening. Here we explore whether socioeconomic status impacts the effectiveness of a single round of low-dose-CT screening, or impacts other causes of death, in the UKLS LDCT screening trial. Methods: IMD quintiles were defined according to UK-wide data, with the deprived group defined as the lower two quintiles (Q1-2) and the less deprived as Q3-5. Follow-up data was obtained for lung cancer diagnosis (median follow-up 9.1 years) and cause of death (median follow-up 9.9 years). Outcomes were compared based on IMD group and trial arm (CT or control). Findings: More deprived quintiles were less likely to respond to the questionnaire, but this population was more likely to be selected for screening by the LLP risk model. Lower IMD quintiles benefitted from low-dose-CT screening in terms of lung cancer survival (HR 1.89, 95% CI 1.16-3.08) to the same extent as upper quintiles (HR 1.87, 95% CI 1.07-3.26). However, there was a bigger impact on deaths due to COPD and emphysema in more deprived quintiles. Interpretation: Whilst LDCT screening benefit for lung cancer was similar, significant impact on the rates of death from other smoking-related diseases, notably COPD and emphysema, was seen primarily in lower socioeconomic groups. Future research is required to confirm how lung cancer screening benefits other disease outcomes. Funding: NIHR Health Technology Assessment Programme; NIHR Policy Research programme; Roy Castle Lung Cancer Foundation.
Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study

Brian L. Rostron,Jia Wang,Arash Etemadi,Sapna Thakur,Joanne T. Chang,Deepak Bhandari,Julianne Cook Botelho,Víctor R. De Jesús,Jun Feng,Mitchell H. Gail,Maki Inoue-Choi,Reza Malekzadeh,Akram Pourshams,Hossein Poustchi,Gholamreza Roshandel,Meredith S. Shiels,Qian Wang,Yuesong Wang,Baoyun Xia,Paolo Boffetta,Paul Brennan,Christian C. Abnet,Antonia M. Calafat,Lanqing Wang,Benjamin C. Blount,Neal D. Freedman,Cindy M. Chang

DOI: https://doi.org/10.3390/ijerph18147349

IF: 4.614

2021-07-09

International Journal of Environmental Research and Public Health

Abstract:Biomarkers of tobacco exposure are known to be associated with disease risk but previous studies are limited in number and restricted to certain regions. We conducted a nested case–control study examining baseline levels and subsequent lung cancer incidence among current male exclusive cigarette smokers in the Golestan Cohort Study in Iran. We calculated geometric mean biomarker concentrations for 28 matched cases and 52 controls for the correlation of biomarker levels among controls and for adjusted odds’ ratios (ORs) for lung cancer incidence by biomarker concentration, accounting for demographic characteristics, smoking quantity and duration, and opium use. Lung cancer cases had higher average levels of most biomarkers including total nicotine equivalents (TNE-2), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and 3-hydroxyfluorene (3-FLU). Many biomarkers correlated highly with one another including TNE-2 with NNAL and N-Acetyl-S-(2-cyanoethyl)-L-cysteine (2CYEMA), and N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine (t4HBEMA) with N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine (3HMPMA) and N-Acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine (4HMBEMA). Lung cancer risk increased with concentration for several biomarkers, including TNE-2 (OR = 2.22, 95% CI = 1.03, 4.78) and NNN (OR = 2.44, 95% CI = 1.13, 5.27), and estimates were significant after further adjustment for demographic and smoking characteristics for 2CYEMA (OR = 2.17, 95% CI = 1.03, 4.55), N-Acetyl-S-(2-carbamoylethyl)-L-cysteine (2CAEMA) (OR = 2.14, 95% CI = 1.01, 4.55), and N-Acetyl-S-(2-hydroxypropyl)-L-cysteine (2HPMA) (OR = 2.85, 95% CI = 1.04, 7.81). Estimates were not significant with adjustment for opium use. Concentrations of many biomarkers were higher at the baseline for participants who subsequently developed lung cancer than among the matched controls. Odds of lung cancer were higher for several biomarkers including with adjustment for smoking exposure for some but not with adjustment for opium use.

public, environmental & occupational health,environmental sciences

Minimally invasive parathyroidectomy: 50 consecutive cases

Association Between Socioeconomic Status and Health Behaviour Change Before and after Non-Communicable Disease Diagnoses: a Multicohort Study

Mendelian Randomization to Explore the Direct or Mediating Associations Between Socioeconomic Status and Lung Cancer.

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

[Temporal arteritis. Study of 43 cases].

Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study

Abstract 1950: Socioeconomic status and lung cancer incidence: An analysis of data from 15 countries in the Lung Cancer Cohort Consortium

Abstract C173: Influence of Socio-Demographic and Lifestyle Factors on Lung Cancer Incidence Among African American and European American

Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY)

Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

Effect of Socioeconomic Status on Stage at Diagnosis of Lung Cancer in a Hospital-Based Multicenter Retrospective Clinical Epidemiological Study in China, 2005-2014.

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

Impurity band and magnetic-field-induced metal-insulator transition in a doped GaAs/AlxGa1-xAs superlattice.

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Family Socioeconomic Position and Lung Cancer Risk: A Meta-Analysis and a Mendelian Randomization Study

Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies

The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis

Abstract 2292: Lung Function and Lung Cancer Risk: a Mendelian Randomization Study of UK Biobank Cohort and the International Lung Cancer Consortium

Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial

Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study